We are live on ! Find out more
TCIM

TIAA CREF Investment Management Portfolio holdings

AUM $141B
1-Year Est. Return 14.18%
This Fund
S&P 500
This Quarter Est. Return
+3.03%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.08%
5 Year Est. Return
+108.37%
10 Year Est. Return
AUM
$130B
AUM Growth
-$153M
Cap. Flow
-$2.19B
Cap. Flow %
-1.68%
Top 10 Hldgs %
14.36%
Holding
3,300
New
213
Increased
1,406
Reduced
1,508
Closed
146

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$199M
2
SPGI icon
S&P Global
SPGI
+$185M
3
AMZN icon
Amazon
AMZN
+$164M
4
MON
Monsanto Co
MON
+$155M
5
CHTR icon
Charter Communications
CHTR
+$140M

Sector Composition

Rank Sector Weight
1 Healthcare 14.68%
2 Technology 14.55%
3 Financials 12.42%
4 Consumer Discretionary 10.82%
5 Industrials 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NM
3201
DELISTED
Navios Maritime Holdings Inc.
NM
-26,380
Closed -$298K
CTG
3202
DELISTED
Computer Task Group, Inc.
CTG
-11,200
Closed -$57K
ZYNE
3203
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-7,863
Closed -$74K
STCN
3204
DELISTED
Steel Connect, Inc. Common Stock
STCN
-18,001
Closed -$247K
SEAC
3205
DELISTED
Seachange International Inc
SEAC
-5,582
Closed -$616K
ALR
3206
DELISTED
AlerisLife Inc
ALR
-26,264
Closed -$601K
SPNE
3207
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-29,482
Closed -$432K
CALA
3208
DELISTED
Calithera Biosciences, Inc
CALA
-1,953
Closed -$222K
ATRS
3209
DELISTED
Antares Pharma, Inc.
ATRS
-471,209
Closed -$410K
VOLT
3210
DELISTED
Volt Information Sciences, Inc.
VOLT
-30,746
Closed -$232K
DRNA
3211
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-53,105
Closed -$285K
CHMA
3212
DELISTED
Chiasma, Inc. Common Stock
CHMA
-21,710
Closed -$199K
HWCC
3213
DELISTED
Houston Wire & Cable Company
HWCC
-18,230
Closed -$127K
PRGX
3214
DELISTED
PRGX Global, Inc.
PRGX
-17,250
Closed -$81K
APEX
3215
DELISTED
Apex Global Brands Inc. Common Stock
APEX
-854
Closed -$456K
PSV
3216
DELISTED
Hermitage Offshore Services Ltd.
PSV
-8,902
Closed -$399K
FOMX
3217
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
-76,145
Closed -$496K
MNI
3218
DELISTED
The McClatchy Company Class A Common Stock
MNI
-8,070
Closed -$85K
FCSC
3219
DELISTED
Fibrocell Science Inc.
FCSC
-5,473
Closed -$205K
NVTR
3220
DELISTED
Nuvectra Corporation Common Stock
NVTR
-27,418
Closed -$148K
ROX
3221
DELISTED
Castle Brands, Inc.
ROX
-206,876
Closed -$194K
FRSH
3222
DELISTED
Papa Murphy's Holdings, Inc
FRSH
-477,904
Closed -$5.71M
GNCA
3223
DELISTED
Genocea Biosciences, Inc.
GNCA
-8,011
Closed -$496K
NAVB
3224
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
-24,732
Closed -$467K
CLD
3225
DELISTED
Cloud Peak Energy Inc
CLD
-208,947
Closed -$407K

Similar funds

TIAA CREF Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, TIAA CREF Investment Management held 3,300 positions worth $130B, down 0.12% from $131B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

TIAA CREF Investment Management's Q2 2016 filing shows 213 new, 1,406 increased, 1,508 reduced and 146 closed positions. Its largest new stake was S&P Global: 1,721,642 shares worth $185M. The largest sale was Synchrony, an estimated $290M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • TIAA CREF Investment Management's largest Q2 2016 buy was S&P Global: 1,721,642 shares worth $185M.
  • TIAA CREF Investment Management added most to Citigroup in Q2 2016, an estimated $199M increase.
  • TIAA CREF Investment Management's biggest Q2 2016 reduction was Synchrony, cutting an estimated $290M.
  • TIAA CREF Investment Management fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $269M.
  • TIAA CREF Investment Management's ten largest holdings make up 14% of its $130B portfolio in Q2 2016.
  • TIAA CREF Investment Management opened 213 new positions and closed 146 in Q2 2016.
  • TIAA CREF Investment Management's portfolio value fell 0.12% quarter-over-quarter to $130B.

Based on TIAA CREF Investment Management's 13F filing for Q2 2016, filed 11 Aug 2016.